Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Investigating the mechanisms of DNA release from cancer cells in esophageal adenocarcinoma patients

EF 2021-22

Résumé
Esophageal adenocarcinoma (EAC) is characterized by low survival rates and has had an increase in incidence in recent decades. Liquid biopsies from EAC patients have the potential to improve diagnosis and prognosis of this disease, by using circulating tumour DNA (ctDNA) and tumour-derived extracellular vesicle DNA (EV-DNA) in patient biofluids as biomarkers of disease progression. However, there is a limited understanding of the mechanisms of ctDNA and EV-DNA release from cancer cells. Particularly, how different treatments, such as chemotherapy or radiation, affect ctDNA and tumour-derived EV-DNA remains poorly understood. The aim of the present study is to use EAC patient samples to elucidate the impact of treatment and treatment response on ctDNA and EV-DNA kinetics and fragmentation. ctDNA and EV-DNA from EAC patient blood samples and from the supernatant of EAC patient-derived organoids treated with in vitro chemotherapy will be isolated. DNA level and fragment size will be compared and associated to different treatments, responses to treatment, development of metastatic disease, and time points of sample collection. This project has the potential to clarify the mechanisms of DNA release from cancer cells, and to identify molecular alterations that could be used for non-invasive diagnosis, prognosis, and detection of treatment resistance in cancer patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466863
Name
Bartolomucci Alexandra
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the mechanisms of DNA release from cancer cells in esophageal adenocarcinoma patients
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Circulating Tumour Dna; Esophageal Adenocarcinoma; Extracellular Vesicles; Liquid Biopsy; Patient-Derived Organoids
Abstract
Esophageal adenocarcinoma (EAC) is characterized by low survival rates and has had an increase in incidence in recent decades. Liquid biopsies from EAC patients have the potential to improve diagnosis and prognosis of this disease, by using circulating tumour DNA (ctDNA) and tumour-derived extracellular vesicle DNA (EV-DNA) in patient biofluids as biomarkers of disease progression. However, there is a limited understanding of the mechanisms of ctDNA and EV-DNA release from cancer cells. Particularly, how different treatments, such as chemotherapy or radiation, affect ctDNA and tumour-derived EV-DNA remains poorly understood. The aim of the present study is to use EAC patient samples to elucidate the impact of treatment and treatment response on ctDNA and EV-DNA kinetics and fragmentation. ctDNA and EV-DNA from EAC patient blood samples and from the supernatant of EAC patient-derived organoids treated with in vitro chemotherapy will be isolated. DNA level and fragment size will be compared and associated to different treatments, responses to treatment, development of metastatic disease, and time points of sample collection. This project has the potential to clarify the mechanisms of DNA release from cancer cells, and to identify molecular alterations that could be used for non-invasive diagnosis, prognosis, and detection of treatment resistance in cancer patients.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bartolomucci, Alexandra
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~